Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer Response

被引：0
|
作者：
Huber, Marie L. [1 ]
Haynes, Laura [1 ]
机构：
[1] Trudeau Inst, Saranac Lake, NY USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 18期
关键词：
BLOOD DONATION; DONORS; CELLS;
D O I：
10.1093/jnci/djs341
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1422 / 1423
页数：2
相关论文
共 50 条
  • [41] Time to next line therapy after initiation of sipuleucel-T in metastatic castration-resistant prostate cancer patients.
    Luu, Dai
    Goldstein, Leanne
    Twardowski, Przemyslaw
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [42] Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
    Holl, Eda K.
    McNamara, Megan A.
    Healy, Patrick
    Anand, Monika
    Concepcion, Raoul S.
    Breland, Coleman D.
    Dumbudze, Igor
    Tutrone, Ron
    Shore, Neal
    Armstrong, Andrew J.
    Harrison, Michael
    Wallace, Joe A.
    Wu, Yuan
    George, Daniel J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (04) : 588 - 592
  • [43] Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
    Eda K. Holl
    Megan A. McNamara
    Patrick Healy
    Monika Anand
    Raoul S. Concepcion
    Coleman D. Breland
    Igor Dumbudze
    Ron Tutrone
    Neal Shore
    Andrew J. Armstrong
    Michael Harrison
    Joe A. Wallace
    Yuan Wu
    Daniel J. George
    Prostate Cancer and Prostatic Diseases, 2019, 22 : 588 - 592
  • [44] Re: Effective Combinatorial Immunotherapy for Castration-Resistant Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2017, 198 (05): : 982 - +
  • [45] Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials
    Antonarakis, Emmanuel S.
    Subudhi, Sumit K.
    Pieczonka, Christopher M.
    Karsh, Lawrence I.
    Quinn, David I.
    Hafron, Jason M.
    Wilfehrt, Helen M.
    Harmon, Matthew
    Sheikh, Nadeem A.
    Shore, Neal D.
    Petrylak, Daniel P.
    CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2426 - 2434
  • [46] Immunotherapy for Castration-Resistant Prostate Cancer
    Sonpavde, Guru
    Kantoff, Philip W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 465 - +
  • [47] Sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) patients ≥80 years-old: Data from PROCEED
    Nabhan, Chadi
    Sartor, A. Oliver
    Cooperberg, Matthew R.
    Armstrong, Andrew J.
    Vacirca, Jeffrey L.
    Concepcion, Raoul S.
    Berry, William R.
    Dhawan, Manish
    Tutrone, Ronald
    Sandler, Andrew
    McCoy, Candice
    Whitmore, James Boyd
    Tyler, Robert Claude
    Higano, Celestia S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [48] An overview of sipuleucel-T Autologous cellular immunotherapy for prostate cancer
    Wesley, Johnna D.
    Whitmore, James
    Trager, James
    Sheikh, Nadeem
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (04) : 520 - 527
  • [49] Immunotherapy for metastatic prostate cancer: where are we at with sipuleucel-T?
    Lue, Chen
    Williams, Andrew K.
    Chalasani, Venu
    Martinez, Carlos H.
    Chin, Joseph
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (01) : 99 - 108
  • [50] Sipuleucel-T in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients >= 80 Years-Old: Data From PROCEED
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (04) : 11 - 11
12345